CTLA4 and neoplasm: Nevertheless, an effective anti-tumor immune response is thwarted by an augmented expression of immune checkpoint molecules including PD-1, its ligand anti-programmed cell death protein-ligand 1 (PD-L1), and CTLA-4 and thus immunosuppressive features of the tumor immune ecosystem [6,7,8,9].